Q1 Earnings Estimate for AKBA Issued By Leerink Partnrs
Akebia Therapeutics, Inc. (NASDAQ:AKBA – Free Report) – Stock analysts at Leerink Partnrs issued their Q1 2025 earnings estimates for shares of Akebia Therapeutics in a research note issued on Monday, April 28th. Leerink Partnrs analyst R. Ruiz anticipates that the biopharmaceutical company will earn ($0.01) per share for the quarter. Leerink Partnrs has a […]
Akebia Therapeutics, Inc. (NASDAQ:AKBA – Free Report) – Stock analysts at Leerink Partnrs issued their Q1 2025 earnings estimates for shares of Akebia Therapeutics in a research note issued on Monday, April 28th. Leerink Partnrs analyst R. Ruiz anticipates that the biopharmaceutical company will earn ($0.01) per share for the quarter. Leerink Partnrs has a […]
